Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

China ousts defence minister, second leader gone in three months

Published

on

China removed its defence minister, the second ousting of a senior leader in three months, raising questions about the stability of the leadership team around Chinese President Xi Jinping.

General Li Shangfu, who has been absent from public view for two months, was dismissed as defence minister and state councillor, according to state media.

China also announced that Qin Gang, who was removed as foreign minister in July, was stripped of his state councillor position.

China’s top legislators, the Standing Committee of the National People’s Congress, approved the removal of both men, state broadcaster CCTV reported, without giving any explanation.

No replacement for Li was named, leaving the country without a defence minister as it prepares to host foreign defence officials at the Beijing Xiangshan Forum on Oct. 29-31.

Li, 65, was last seen in public on Aug. 29. Reuters reported last month that he was under investigation for suspected corruption related to equipment procurement and development.

He had only been in the job since March, when Xi started his precedent-breaking third term as head of state. Li, who is under U.S. sanctions over Beijing’s purchase of combat aircraft and equipment from Russia, is China’s shortest-serving defence minister.

Qin had also served less than a year before he disappeared from public view and was replaced by his predecessor, Wang Yi. No formal explanation has been given but the Wall Street Journal cited sources saying Qin had an extramarital affair while he was ambassador to the United States.

Continue Reading

News

Will the U.S. approve MDMA therapy?

Published

on

MDMA is a drug commonly known as molly or ecstasy.

Some medical professionals say it can be helpful for people with post-traumatic stress disorder — which is why a group has been fighting to get MDMA legalized as a prescription drug.

Currently, the U.S. Food and Drug Administration is reviewing an application to use MDMA to treat PTSD. The agency is expected to announce its ruling as soon as August.

Anna Silman, a features correspondent with Business Insider joins Veronica Dudo to discuss. #IN AMERICA TODAY #trending #drugs #MDMA #MDMATherapy #business #pharmaceutical

Continue Reading

News

Apple responds to crushing iPad Pro criticism

Published

on

Apple issued an apology following backlash over a recent advertisement for the latest iPad Pro.

On this episode of Ahron & Mike Live – Painted Panda dogs confuse zoo goers, luxury Police cars cruise the roads, Siri meets up with ChatGpt and Apple’s “Crush” iPad ad faces overwhelming backlash.

Ticker’s Ahron Young & Mike Loder discuss. #featured #trending

Continue Reading

Money

Why the meme-stock frenzy is unlikely to repeat

Published

on

GME shares surge 74%, but experts stress a meme-stock frenzy resurgence is unlikely due to fundamental differences in the company’s financial situation.

Australia’s budget unveils a second consecutive surplus of A$9.3 billion, prioritising the critical minerals industry and green energy initiatives to reduce reliance on Chinese supply.

Also, GameStop shares have surged 74%, but experts caution against expecting a repeat of the 2021 meme-stock frenzy. #featured #trending

Continue Reading

Trending Now